Research Integrity, AI Applications for Drug Discovery Covered in Opening and Closing Plenaries at PharmSci 360

Registration for Now Open

6 September 2024 -- Virginia, US -- AAPS is excited to announce the opening and closing plenary speakers for the 2024 PharmSci 360, taking place October 20-23 in Salt Lake City, Utah.

PharmSci 360 opens on Sunday, October 20, with a panel discussion on research integrity featuring Ivan Oransky, M.D., Co-founder of Retraction Watch; Brian Nosek, Ph.D., Co-founder and Executive Director of the Center for Open Science; and David Allison, Ph.D., Dean of the School of Public Health at Indiana University. Lynn Kamen, Ph.D., Scientific Officer at BioAgilytix Labs, will moderate the panel.

Piet van der Graaf, Pharm.D., Ph.D., Senior Vice President and Head of Quantitative Systems, Pharmacology, at Certara, closes out PharmSci 360 on Wednesday, October 23, with a talk on AI and AI-assisted approaches in pharmaceutical discovery and development.

“Both research integrity and AI applications to drug development are important topics in today’s pharmaceutical industry,” AAPS 2024 PharmSci 360 Scientific Programming Committee Chair Amit Desai, Ph.D., said. “I strongly encourage anyone who is involved in the pharmaceutical sciences to attend PharmSci 360 and learn from these experts."
“Credibility in our industry is so crucial,” 2024 AAPS President, Gopi Shankar, Ph.D., M.B.A., FAAPS, said. “Treatments that improve the lives of patients worldwide must be supported on a foundation of research that is accurate and sincere. I’m also excited about the closing plenary and learning more about how AI will transform the development of drugs in the near future.”

To register for PharmSci 360, visit www.aaps.org/register.

About AAPS
American Association of Pharmaceutical Scientists (AAPS) is a 501(c)(3) non-profit association of more than 7,000 scientists and professionals employed in academia, industry, regulatory, and other research related to the pharmaceutical sciences worldwide. Its mission is to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health, which members pursue through four peer-reviewed journals and various events in person and online. www.aaps.org
AAPs PharmSci 360 delivers research from across the pharmaceutical continuum, from discovery to delivery, and all stages in between. Thousands of scientists from across the globe converge to discuss cutting-edge breakthroughs, technologies, and techniques in symposia and poster presentations at this science-first event. Visit: aaps.org/pharmsci360.